Utah Medical Products, Inc.
UTMD
$52.37
-$0.50-0.95%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -8.47% | -3.80% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -8.47% | -3.80% | |||
| Cost of Revenue | -8.76% | 1.35% | |||
| Gross Profit | -8.26% | -7.21% | |||
| SG&A Expenses | 3.26% | -2.65% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.73% | -1.23% | |||
| Operating Income | -13.02% | -7.78% | |||
| Income Before Tax | -13.52% | -0.76% | |||
| Income Tax Expenses | 15.58% | -18.73% | |||
| Earnings from Continuing Operations | -18.55% | 3.19% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -18.55% | 3.19% | |||
| EBIT | -13.02% | -7.78% | |||
| EBITDA | -11.15% | -5.68% | |||
| EPS Basic | -16.39% | 4.78% | |||
| Normalized Basic EPS | -11.67% | -3.78% | |||
| EPS Diluted | -16.10% | 4.32% | |||
| Normalized Diluted EPS | -11.67% | -3.78% | |||
| Average Basic Shares Outstanding | -2.58% | -1.52% | |||
| Average Diluted Shares Outstanding | -2.58% | -1.52% | |||
| Dividend Per Share | 1.67% | 0.00% | |||
| Payout Ratio | 0.21% | -0.06% | |||